跳至主要内容
临床试验/NCT01488396
NCT01488396已完成4 期

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

Mahidol University1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2007年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
31
试验地点
1
主要终点
dry eyes symptoms : dryness, gritty, photophobia, burning and pain

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of 0.05% cyclosporin ophthalmic emulsion (Restasis) in patients with Stevens-Johnson syndrome that have dry eyes by subjective symptoms and signs.

详细描述

Stevens-Johnson syndrome patients in chronic stage who have dry eys symptoms and signs will be treated with 0.05%cyclosporin ophthalmic emulsion(Restasis)twice a day for 6 months, compare results at 0,2,4,6 months include dry eye symptoms, corneal staining (Fluorescein, Rose Bengal), Schirmer I,FCT and impression cytology

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females, of legal age of consent
  • Patient with Stevens-Johnson syndrome in chronic stage or has symptoms more than 3 months and has dry eye symptoms
  • Dry eye symptoms are defined as
  • has dry eye symptom everyday for more than 3 months
  • has foreign body sensation frequently
  • use tear substitutes more than 3 times per day
  • Tear test shaw abnormalities at least 1 of 2 of following:
  • Schirmer test without anesthesia is not more than 5 millimeters in 5 minutes
  • Fluorescein clearance test at first 10 minutes is not more than 3 millimeters and has at least 1 of 3 of the following:
  • 2.1.Rose Bengal score is not less than 4 2.2.Fluorescein stain at cornea 2.3.Impression cytology is consistent to dry eye
  • Patent punctum

排除标准

  • Age < 18 years old
  • Patients with Steven Johnson syndrome without dry eye
  • Patients used oral cyclosporine or anticholinergic drug within past 2 months
  • Patients with HIV or immunocompromise status
  • Patients with active ocular infections and patients with a history of herpes keratitis
  • Patients with known or suspected hypersensitivity to any of the ingredients in the formula (cyclosporine, glycerin, castor oil, polysorbate 80, carbomer 1342)
  • Female patients are pregnant or nursing

研究组 & 干预措施

0.05%cyclosporin eye drop

Experimental

干预措施: 0.05%cyclosporin eye drop (Drug)

结局指标

主要结局

dry eyes symptoms : dryness, gritty, photophobia, burning and pain

时间窗: 0, 2, 4, 6 months

次要结局

  • Corneal staining(0, 2, 4, 6 months)
  • Schirmer I test(0, 6 months)
  • Fluorescein tear break up time(0, 2. 4. 6 months)
  • Fluorescein clearance test (FCT)(0, 6 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pinnita Prabhasawat

Associated professor

Mahidol University

研究点 (1)

Loading locations...

相似试验

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens... | 临床试验